Authority: IC 16-41-39.4-1

Affected: IC 16-41-39.4

Sec. 21. "Retesting" means additional testing to monitor a child's blood lead level over time in accordance with the following schedule, unless a primary care physician or local health department determines retesting should occur within shorter intervals:

1. (1) Within twelve (12) months for results between zero (0) and three and four-tenths (3.4) μg/dL.
2. (2) Within three (3) to six (6) months for results between three and five-tenths (3.5) and nine and nine-tenths (9.9) μg/dL.
3. (3) Within one (1) to three (3) months for results between ten (10) and nineteen and nine-tenths (19.9) μg/dL.
4. (4) Within two (2) weeks to one (1) month for results between twenty (20) and forty-four and nine-tenths (44.9) μg/dL.
5. (5) By the venous method within one (1) month after completion of chelation therapy for results greater than forty-five (45) μg/dL.

(Indiana Department of Health; 410 IAC 29-1-21; filed Jan 2, 2007, 2:49 p.m.: 20070131-IR-410050189FRA; filed Apr 20, 2009, 3:12 p.m.: 20090520-IR-410080318FRA; readopted filed Sep 11, 2013, 3:19 p.m.: 20131009-IR-410130346RFA; readopted filed Nov 13, 2019, 3:14 p.m.: 20191211-IR-410190391RFA; filed Sep 1, 2022, 4:06 p.m.: 20220928-IR-410220119FRA; readopted filed Nov 14, 2025, 11:18 a.m.: 20251210-IR-410240588RFA)